Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Cholera Outbreak in Haiti

Epidemiology, Control, and Prevention

Lucien, Mentor Ali Ber, MD*; Adrien, Paul, MD; Hadid, Hind, MD; Hsia, Tammy, BA§; Canarie, Michael F., MD; Kaljee, Linda M., PhD; Kilgore, Paul E., MPH, MD¶#; Parke, Dana M., BA; Joseph, Gerard A., MD*; Lafosse, Elsie, MD*; Zervos, Marcus J., MD; Boncy, Jacques, MD*

Infectious Diseases in Clinical Practice: January 2019 - Volume 27 - Issue 1 - p 3–11
doi: 10.1097/IPC.0000000000000684
Review Articles

In October 2010, a massive cholera outbreak struck Haiti, and subsequently, thousands of cholera cases have been documented throughout Haiti. After much controversy about its origin, scientific evidence demonstrated its importation from Nepalese United Nations Peacekeepers. Despite national and international efforts to combat this outbreak (such as oral cholera vaccine campaigns), challenges related to funding, water and sanitation infrastructure, and poverty make it difficult to eliminate cholera from Haiti. This article discusses the recent cholera epidemic in Haiti, its origin and spread throughout Haiti, the specific nature and microbiologic characteristics of the pathogen, and ongoing disease management and control efforts. Importantly, this article suggests a future research agenda identifying best strategies for eliminating cholera in Haiti.

From the *Laboratoire National de Santé Publique, Ministère de la Santé Publique et de la Population d'Haiti;

Direction d'Épidémiologie, de Laboratoire et de Recherches, Ministère de la Santé Publique et de la Population, Port-au-Prince, Haiti;

Division of Infectious Diseases, Henry Ford Health System;

§Wayne State University School of Medicine, Detroit, MI;

Department of Pediatrics, Yale University School of Medicine, New Haven, CT;

The Global Health Initiative, Henry Ford Health System; and

#Eugene Applebaum School of Pharmacy, Wayne State University, Detroit, MI.

Correspondence to: Mentor Ali Ber Lucien, MD, Laboratoire National de Santé Publique d'Haïti, No. 52 Route de Delmas 33, commune de Delmas, Port-au-Prince HT6120, Haiti. E-mail:

Author Dr Marcus Zervos reports grants from Merck, Genentech, and Cempra outside the scope of the submitted work; all other authors declare that they have no competing interests.

This study was supported by the SP-Haiti Lab project.

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.